80547-80-4

Basic information

• Product Name: Benzaldehyde, 3,4-dimethoxy-5-methyl-
• CAS NO: 80547-80-4
• Molecular Formula: C10H12O3
• Molecular Weight: 180.203
• Mol File: 80547-80-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3,4-dimethoxy-5-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3,4-dimethoxy-5-methyl-(80547-80-4)
• EPA Substance Registry System: Benzaldehyde, 3,4-dimethoxy-5-methyl-(80547-80-4)

Safety Data

• Hazardous Substances Data: 80547-80-4(Hazardous Substances Data)

Upstream product

• 28276-04-2 3-(chloromethyl)-4-hydroxy-5-methoxybenzaldehyde 
• 87743-10-0 3-((dimethylamino)methyl)-4-hydroxy-5-methoxybenzaldehyde 
• 121-33-5 vanillin 
• 32263-14-2 4-hydroxy-3-methoxy-5-methylbenzaldehyde 
• 74-88-4 methyl iodide 
• 77-78-1 dimethyl sulfate 
• 6948-30-7 5-bromoveratralaldehyde 
• 594-27-4 tetramethylstannane 
• 80547-77-9 3-methyl-4,5-dimethoxybenzoic acid 
• 80547-86-0 3-methyl-4,5-dihydroxyacetophenone 
• 35236-40-9 3-methylpyrocatechol diacetate 
• 82628-68-0 3,4-dihydroxy-5-methylbenzaldehyde 
• 80547-79-1 (3,4-dimethoxy-5-methylphenyl)methanol 

Downstream Products

• 100668-75-5 3,4-dimethoxy-5-methylphenol 
• 1319714-04-9 1,2-dimethoxy-5-(methoxymethoxy)-3-methylbenzene 
• 1401427-20-0 C₄₂H₄₀O₁₁ 
• 1415689-47-2 methyl 2,3-dimethoxy-6-(methoxymethyl)-4-methylbenzoate 
• 1415689-52-9 methyl 6-(chloromethyl)-2,3-dimethoxy-4-methylbenzoate 
• 80547-79-1 (3,4-dimethoxy-5-methylphenyl)methanol 

Relevant articles and documents

Tetrahydrocoptisine derivative and applications thereof

The present invention relates to a compound as shown in a formula (VII), a preparation method and applications thereof in medicines. In particular, the present invention relates to a derivative of the compound as shown in the formula (VII), a preparation method, and the applications of the derivative used as a therapeutic agent in prevention and treatment of hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, II-type diabetes, hyperglycemia, obesity or insulin resistance syndrome and metabolic syndrome. The compound disclosed by the present invention can also reduce total cholesterol, LDL-cholesterol and triglyceride, and increases expression of a liver LDL receptor and decreases expression of PCSK9.

6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors

Although an extensive body of scientific and patent literature exists describing the development of HIV-1 integrase (IN) inhibitors, Merck's raltegravir and Gilead's elvitegravir remain the only IN inhibitors FDA-approved for the treatment of AIDS. The em

Regioselective reactions of highly substituted arynes

"Chemical Equation Presented" The fully regioselective reactivity of four new highly substituted silyl aryl triflate aryne precursors in aryne acyl-alkylation, acyl-alkylation/ condensation, and heteroannulation reactions is reported. The application of these more complex arynes provides access to diverse natural product scaffolds and obviates late-stage functlonallzation of aromatic rings.